Form 8-K - Current report:
SEC Accession No. 0001104659-24-075724
Filing Date
2024-06-27
Accepted
2024-06-27 17:00:13
Documents
14
Period of Report
2024-06-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2418268d1_8k.htm   iXBRL 8-K 37166
  Complete submission text file 0001104659-24-075724.txt   263845

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gpcr-20240625.xsd EX-101.SCH 3893
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gpcr-20240625_def.xml EX-101.DEF 27150
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gpcr-20240625_lab.xml EX-101.LAB 37087
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gpcr-20240625_pre.xml EX-101.PRE 25774
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2418268d1_8k_htm.xml XML 6191
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41608 | Film No.: 241080098
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)